American Hip Institute Research Foundation, Chicago, Illinois, USA.
AMITA Health St Alexius Medical Center, Hoffman Estates, Illinois, USA.
Am J Sports Med. 2022 Jan;50(1):58-67. doi: 10.1177/03635465211055175. Epub 2021 Nov 24.
The effect of low body mass index (BMI) on outcomes in female athletes is unknown.
(1) To report minimum 2-year patient-reported outcomes and return to sports for high-level female athletes with low BMI undergoing hip arthroscopy for femoroacetabular impingement syndrome and (2) to compare results with those of a propensity-matched control group of high-level female athletes with a normal BMI.
Cohort study; Level of evidence, 3.
Data were collected on all professional, collegiate, and high school female athletes who had a low BMI and underwent primary hip arthroscopy between September 2009 and March 2017 at our institute. Return-to-sports status and minimum 2-year patient-reported outcomes were collected for the modified Harris Hip Score (mHHS), Nonarthritic Hip Score, Hip Outcome Score-Sport Specific Subscale, and visual analog scale (VAS) for pain. The percentage of patients achieving the minimal clinically important difference (MCID), Patient Acceptable Symptom State (PASS), and maximum outcome improvement satisfaction threshold (MOIST) was also recorded. These patients were propensity matched to high-level female athletes with a normal BMI for comparison.
A total of 21 high-level female athletes (25 hips) with a mean ± SD follow-up of 58.9 ± 31.5 months were included. They demonstrated significant improvement from preoperatively to latest follow-up for the mHHS, Nonarthritic Hip Score, Hip Outcome Score-Sport Specific Subscale, and VAS ( < .001). When outcomes were compared with those of the control group, female athletes with low BMI demonstrated lower rates of achieving the MCID for the mHHS (54.5% vs 77.4%; = .041), PASS for the International Hip Outcome Tool-12 (45.5% vs 72.6%; = .022), and MOIST for the VAS (31.8% vs 56.5%; = .047). There were no other significant differences in the rate of achieving the MCID, PASS, or MOIST between the groups ( > .05). Female athletes with low BMI also had higher rates of revision when compared with the control group (27.2% vs 10.6%; = .049), but there were comparable return-to-sports rates (75.0% vs 74.5%; > .05).
High-level female athletes with low BMI undergoing primary hip arthroscopy for femoroacetabular impingement syndrome demonstrated significant improvement in patient-reported outcomes and acceptable rates of return to play. When compared with a control group with normal BMI, they exhibited higher rates of revision and lower rates of achieving the MCID for the mHHS, PASS for the International Hip Outcome Tool-12, and MOIST for the VAS.
低体重指数(BMI)对女性运动员的影响尚不清楚。
(1)报告行髋关节镜治疗股骨髋臼撞击综合征的低 BMI 女性高水平运动员至少 2 年的患者报告结局和重返运动情况;(2)并与 BMI 正常的高 BMI 女性运动员的倾向匹配对照组进行比较。
队列研究;证据水平,3 级。
在我院,对 2009 年 9 月至 2017 年 3 月间接受初次髋关节镜手术的所有专业、大学和高水平女性运动员进行了低 BMI 并接受初次髋关节镜手术的女性运动员进行了回顾性研究。收集改良 Harris 髋关节评分(mHHS)、非关节炎髋关节评分、髋关节结果评分-运动特异性量表和视觉模拟评分(VAS)疼痛的最低临床重要差异(MCID)、患者可接受的症状状态(PASS)和最大结局改善满意度阈值(MOIST)的最低 2 年患者报告结局。这些患者与 BMI 正常的高 BMI 女性运动员进行倾向匹配以进行比较。
共纳入 21 名高水平女性运动员(25 髋),平均随访时间为 58.9±31.5 个月。他们的 mHHS、非关节炎髋关节评分、髋关节结果评分-运动特异性量表和 VAS 从术前到末次随访均有显著改善(均<0.001)。与对照组相比,低 BMI 的女性运动员在 mHHS 的 MCID(54.5%对 77.4%; =0.041)、国际髋关节结果工具-12 的 PASS(45.5%对 72.6%; =0.022)和 VAS 的 MOIST(31.8%对 56.5%; =0.047)方面的达标率较低。两组之间 MCID、PASS 或 MOIST 的达标率差异无统计学意义(均>0.05)。与对照组相比,低 BMI 的女性运动员的翻修率更高(27.2%对 10.6%; =0.049),但重返运动率相当(75.0%对 74.5%;>0.05)。
行髋关节镜治疗股骨髋臼撞击综合征的低 BMI 女性高水平运动员的患者报告结局有显著改善,且有可接受的重返运动率。与 BMI 正常的对照组相比,他们的翻修率更高,而 mHHS 的 MCID、国际髋关节结果工具-12 的 PASS 和 VAS 的 MOIST 的达标率较低。